Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Nour Lab Consult AS
AS
Active
Org 932367645
Trippestadsvingen 12, 1812
Askim
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2023 · 2 years old
0 employees
Monitor
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Nour Lab Consult AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
2M
2M
1M
1M
0M
2023: 0M
0M
2023
2024: 2M
2M
2024
2025: 2M (0% vs 2024)
2M
0%
2025
EBITDA
NOK millions
0M
0M
0M
-1M
-1M
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
Income statement
NOK thousands
Item
2025
2024
2023
Revenue
2 443
1 767
102
Staff expenses
−1 568
−1 131
−0
EBITDA
149
186
5
Depreciation & amort.
−36
−0
−0
EBIT
114
186
5
Net financials
−4
30
−1
Profit before tax
109
215
4
Tax
27
48
−0
Net profit
83
167
4
Balance sheet
NOK thousands
Item
2025
2024
2023
Total assets
1 410
476
120
Equity
279
196
29
Long-term debt
543
0
0
Short-term debt
588
280
91
Total debt
1 131
280
91
Financial ratios
5-year trend
EBITDA margin
6,1 %
This company
15,8 %
Market median
This company
Market median
61% below market
2023
2025
Equity ratio
19,8 %
This company
38,2 %
Market median
This company
Market median
48% below market
2023
2025
Return on equity
29,7 %
This company
18,4 %
Market median
This company
Market median
61% above market
2023
2025
Net profit margin
3,4 %
This company
8,1 %
Market median
This company
Market median
58% below market
2023
2025
Asset turnover
1,73×
This company
1,12×
Market median
This company
Market median
54% above market
2023
2025
Debt / equity
4,05×
This company
0,62×
Market median
This company
Market median
553% above market
2023
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-10-06 – 2023-12-31
View
PDF
More on Nour Lab Consult AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
